Quick Answer
ACCENDRA HEALTH INC/VA/ reported Revenue (ASC 606) of $2.76 billion for fiscal year 2025.
ACCENDRA HEALTH INC/VA/ Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $2.76B | +3.1% |
| 2024 | $2.68B | +5.0% |
| 2023 | $2.55B | -74.4% |
| 2022 | $9.96B | +1.7% |
| 2021 | $9.79B | +15.4% |
| 2020 | $8.48B | -7.9% |
| 2019 | $9.21B | -2.2% |
| 2018 | $9.42B | +1.1% |
| 2017 | $9.32B | -4.2% |
| 2016 | $9.72B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $697.26M | +1.5% | +2.3% |
| June 30, 2025 | $681.92M | +3.3% | -74.1% |
| March 31, 2025 | $2.63B | +0.7% | +283.2% |
| September 30, 2024 | $686.85M | -73.5% | +4.0% |
| June 30, 2024 | $660.40M | -74.2% | -74.7% |
| March 31, 2024 | $2.61B | +3.6% | +0.8% |
| September 30, 2023 | $2.59B | +3.8% | +1.1% |
| June 30, 2023 | $2.56B | +2.5% | +1.6% |
- ACCENDRA HEALTH INC/VA/ showed an increase of +3.1% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, ACCENDRA HEALTH INC/VA/’s revenue (asc 606) has declined by 71.6% (from $9.72 billion to $2.76 billion).
- The most recent figure is from ACCENDRA HEALTH INC/VA/’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: